Previous 10 | Next 10 |
home / stock / thrbf / thrbf news
Therma Bright ([[THRBF]] -3.7%) enters into a distribution agreement to white label and distribute a 15-minute rapid COVID-19 antibody test for detecting IgG and IgM antibodies against SARS-CoV-2. The new product will be branded Therma Bright's AcuVid™ COVID-19 Rapid Antibody Test...
Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has entered into...
Silicon Valley tech firm brings encrypted solution for tracking Canadian developer's 15-minute Covid19 rapid antigen test for point of care, and then at-home testing Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Afero has entered into a memorandum of understanding (MOU) agreement wi...
Toronto, Ontario--(Newsfile Corp. - April 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company") , developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce successful preliminar...
Therma Bright (THRBF) announces that it has received CE approval certification from an EU competent authority of Belgium for its AcuVid COVID-19 Rapid Antigen Saliva Test.The company has secured a conditional purchase order for 100K units through a new global distribution partner, M...
New global distribution partner McWilliams Collective secures test kit order from European client Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid ™ COVID-19 Rapid Antigen Saliva Test and other p...
Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that an initial phase o...
Therma Bright (THRBF) announces that it has received IRB approval and subsequently submitted to Health Canada seeking approval to conduct a clinical performance study of its AcuVid Covid-19 Rapid Saliva-based Antigen Test."This FDA action should positively impact the approval of our test...
Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has received IR...
Developer of the AcuVidTM COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, Therma Bright ([[THRBF]] +13.7%) enters business agreement with Ridge Global, the consultancy founded by Governor Tom Ridge, the first U.S. S...
News, Short Squeeze, Breakout and More Instantly...
Therma Bright Inc. Company Name:
THRBF Stock Symbol:
OTCMKTS Market:
Company To Begin Embedding Solution Onto Each 15-Minute COVID-19 Rapid Antigen Test Cartridge Toronto, Ontario--(Newsfile Corp. - August 5, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company") , developer of its 'smart-enabled' AcuVid™ COVID-19 Rapid Antigen Saliva Test...
Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it ha...
Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide an update o...